Brand and Compounded Access
Every route to tirzepatide, approved and compounded, with what each costs and requires.
Every route to tirzepatide, approved and compounded, with what each costs and requires.
Every page in this section states what we could verify and what we could not. Where a programme publishes nothing, that absence is recorded rather than filled in.
For context: across 32 tracked tirzepatide telehealth programmes, 17 publish a price we could capture, and the cheapest verified all-in cost is $215 a month at a 10 mg maintenance dose — about $2,580 for a first year. Compounded preparations are not FDA-approved. Prices captured 2026-08-05.
All-in monthly cost at 10 mg
| Programme | All-in at 10 mg | First year | Per mg | Structure | Evidence |
|---|---|---|---|---|---|
| NexLife | $215 | $2,580 | $5.38 | flat at every dose | ✓ verified at source |
| Join Fridays | $249 | $2,988 | $6.22 | flat at every dose | third-party figure |
| Yucca Health | $258 | $3,096 | $6.45 | flat at every dose | ✓ verified at source |
| Mochi Health | $278 | $3,336 | $6.95 | flat at every dose | ✓ verified at source |
| IVIM Health | $278 | $3,219 | $6.95 | rises with dose | ✓ verified at source |
| ShedRx | $289 | $3,318 | $7.22 | rises with dose | ✓ verified at source |
| SkinnyRx | $299 | $3,588 | $7.47 | flat at every dose | ✓ verified at source |
| Amble Health | $300 | $3,600 | $7.50 | flat at every dose | third-party figure |
| TrimRx | $349 | $4,188 | $8.72 | flat at every dose | ✓ verified at source |
| Lavender Sky Health | $352 | $3,971 | $8.80 | rises with dose | ✓ verified at source |
| Found | $398 | $4,776 | $9.95 | flat at every dose | third-party figure |
| MEDVi | $399 | $4,788 | $9.97 | flat at every dose | ✓ verified at source |
| Remedy Meds | $399 | $4,788 | $9.97 | flat at every dose | third-party figure |
| Eden | $408 | $4,796 | $10.20 | rises with dose | ✓ verified at source |
| Henry Meds | $509 | $6,008 | $12.72 | rises with dose | third-party figure |
| LifeMD | $548 | $6,576 | $13.70 | flat at every dose | third-party figure |
First-year all-in cost
Every page in this section
Zepbound Access
Every route to FDA-approved tirzepatide for weight management.
Mounjaro Access
The diabetes label, and why it is covered more often.
LillyDirect Self-Pay
Manufacturer cash pricing and the refill condition.
Brand vs Compounded
What the approval status actually buys.
Insurance Coverage for Zepbound
Prior authorisation, exclusions and appeals.
Medicare and Tirzepatide
The bridge programme and who qualifies.
Savings Cards and Copay Programmes
Who is eligible and who is excluded.
Compounded Tirzepatide Legality
The statutory pathway, in plain terms.
Compounded Supply Risk
What regulatory change does to your refill.
Oral and Sublingual Tirzepatide
Compounded formats and the evidence gap.
Microdosing Programmes
Fractional dosing, priced separately for a reason.
Switching Between Brand and Compounded
Dose continuity, concentration changes and what to confirm.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.